Scientists develop scans that light up aggressive cancer tumors for better treatment
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
GlobalData on MSN1d
GSK’s lung cancer therapy gains EMA PRIME designation
GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has gained priority medicines (PRIME) ...
FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer
The FDA delays Johnson & Johnson's SC amivantamab approval for NSCLC over facility inspection issues, unrelated to product ...
Science Daily5d
Lung Cancer News
including diseases like lung cancer. And devising ways to sense these compounds could help doctors provide early diagnoses ... Researchers Identify Key Mechanism in Human Lung Development Oct. 31 ...
cambridgeindependent5d
World-first urine test to detect lung cancer being developed by University of Cambridge scientists
A first-of-its-kind urine test for the early detection of lung cancer has been developed by University of Cambridge ...
Russia’s cancer vaccine is ready. Here’s why it matters
Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of cost, will treat patients instead of preventing the disease in the general ...
Science Daily6d
Lung Disease News
including diseases like lung cancer. And devising ways to sense these compounds could help doctors provide early diagnoses ... Researchers Identify Key Mechanism in Human Lung Development Oct. 31 ...
U of I professor pioneering cancer treatment
A professor at the University of Illinois is pioneering cancer research that could curb tumor growth. Erik Nelson is an ...
NIH Debunks the Myth: Treatment Isn’t the Only Key to Reducing Cancer Deaths
An NIH modeling study examined the individual and combined effects of cancer prevention, screening, and treatment. A study ...
EurekAlert!1d
Top cancer research advances at MSK in 2024
Laboratory research teams across the institution worked to advance the global understanding of cancer and to develop new ...
Pharmabiz1d
GSK’s B7-H3-targeted ADC, GSK’227, receives EMA PRIME designation in relapsed extensive-stage small-cell lung cancer
GSK’s B7-H3-targeted ADC, GSK’227, receives EMA PRIME designation in relapsed extensive-stage small-cell lung cancer: London, UK Tuesday, December 17, 2024, 12:00 Hrs [IST] GS ...